B-cell Lymphoma - MD Anderson Cancer Center

MyChart Donate Today

• Clinical Trials
• Locations
• Careers
• Contact Us
• Languages
  • Español
  • عربى
  • 中文
  • Türkçe

Request an Appointment

• Request an Appointment
• New Patients
• Current Patients
• Referring Physicians

• Patients & Family
  • Becoming Our Patient
    • Becoming Our Patient
    • Becoming Our Patient Home
    • Why MD Anderson
    • Planning for Care
    • Getting to MD Anderson
    • While You're Here
    • International Center
    • Services and Amenities
    • Insurance & Billing
    • Second Opinion Appointments
  • Diagnosis & Treatment
    • Diagnosis & Treatment
    • Diagnosis & Treatment Home
    • Cancer Types
    • A New Diagnosis
    • Treatment Options
    • Care Centers & Clinics
    • Emotional & Physical Effects
    • Patient Support
    • Clinical Trials
  • Supporting a Loved One
    • Supporting a Loved One
    • Supporting a Loved One Home
    • Caregiver Roles & Challenges
    • Children and Teens
    • Taking Care of Yourself
    • Helping an MD Anderson Patient
    • Dealing with Loss
  • Life After Cancer
    • Life After Cancer
    • Life After Cancer Home
    • Follow-up Care After Cancer Treatment
    • Long-Term Effects of Cancer
    • Social & Emotional Impacts of Cancer
    • Legal & Financial Impacts of Cancer
    • Survivorship Week
  • Request an Appointment Current Patients

    Find information and resources for current and returning patients.

    Clinical Trials

    Learn about clinical trials at MD Anderson and search our database for open studies.

• Prevention & Screening
  • Manage Your Risk
    • Manage Your Risk
    • Manage Your Risk Home
    • Tobacco Control
    • Diet
    • Body Weight
    • Physical Activity
    • Skin Safety
    • HPV
    • Hepatitis
    • Alcohol
  • Family History
    • Family History
    • Family History Home
    • Genetic Testing
    • Hereditary Cancer Syndromes
    • Genetic Counseling and Testing FAQs
  • Cancer Screenings
    • Cancer Screenings
    • Cancer Screenings Home
    • Mammograms & Breast Cancer Screening
    • Cervical Cancer Screening
    • Colorectal Cancer Screening
    • Endometrial Cancer Screening
    • Liver Cancer Screening
    • Lung Cancer Screening
    • Mobile Mammography
    • Ovarian Cancer Screening
    • Prostate Cancer Screening
    • Skin Cancer Screening
    • Women's Cancer Screening
    • Men's Cancer Screening
  • Cancer Prevention Center

    The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

• Donors & Volunteers
  • Donate
    • Donate
    • Donate Home
    • Raise Money
    • Honor Loved Ones
    • Create Your Legacy
    • Endowments
    • Caring Fund
    • Matching Gifts
    • Foundation and Corporation Relations
  • Volunteer
    • Volunteer
    • Volunteer Home
    • On-Site Volunteers
    • Volunteer Endowment
    • Patient Experience
    • Children's Cancer Hospital Councils
  • Other Ways to Help
    • Other Ways to Help
    • Other Ways to Help Home
    • Give Blood
    • Shop MD Anderson
    • Children's Art Project
    • Donate Goods or Services
    • Attend Events
    • Cord Blood Bank
  • Corporate Alliances
    • Corporate Alliances
    • Corporate Alliances Home
    • Current Alliances
  • Join the Campaign to End Cancer

    Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define MD Anderson.

• For Physicians
  • Refer a Patient
    • Refer a Patient
    • Refer a Patient Home
    • Health Care Provider Resource Center
    • Referring Provider Team
    • Insurance Information
    • International Referrals
    • myMDAnderson for Physicians
    • Second Opinion Pathology
  • Clinical Trials
    • Clinical Trials
    • Clinical Trials Home
  • Clinical Tools & Resources
    • Clinical Tools & Resources
    • Clinical Tools & Resources Home
    • Clinical Calculators
    • Clinical Practice Algorithms
  • myMDAnderson for Physicians

    Our personalized portal helps you refer your patients and communicate with their MD Anderson care team.

• Research
  • Departments, Labs and Institutes
    • Departments, Labs and Institutes
    • Departments, Labs and Institutes Home
    • Departments and Divisions
    • Labs
    • Research Centers and Programs
    • Institutes
    • Specialized Programs of Research Excellence (SPORE) Grants
  • Research Areas
    • Research Areas
    • Research Areas Home
    • Basic Science
    • Translational Research
    • Clinical Research
    • Prevention & Personalized Risk Assessment
  • Research Resources
    • Research Resources
    • Research Resources Home
    • Excellence in Science
    • Core Facilities and Services
    • Conferences & Seminars
    • Why Research at MD Anderson
    • STRIDE
    • NCI-Designated Cancer Center
  • Clinical Trials

    As part of our mission to eliminate cancer, MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

• Education & Training
  • Degree-Granting Schools
    • Degree-Granting Schools
    • Degree-Granting Schools Home
    • School of Health Professions
    • MD Anderson UTHealth Houston Graduate School
  • Research Training
    • Research Training
    • Research Training Home
    • Early Career Pathway Programs
    • Predoctoral Training
    • Postdoctoral Training
    • Mentored Faculty Programs
    • Career Development
  • Clinical Training
    • Clinical Training
    • Clinical Training Home
    • Graduate Medical Education
    • Clinical Education for Non-Physicians
    • Nursing Education & Training
    • Continuing Education & Review Courses
    • Simulation Center
  • Continuing Education & Professional Development
    • Continuing Education & Professional Development
    • Continuing Education & Professional Development Home
    • Continuing Professional Education/Conferences
    • Administrative Internships & Fellowships
    • Cancer Survivorship Professional Education
    • Leadership Institute
    • Patient Home Visits
  • Education Resources
    • Education Resources
    • Education Resources Home
    • Alumni Relations
    • Education Design Services
    • Awards & Recognitions
    • Academic Mentoring Council
    • Why MD Anderson & Houston
  • Outreach Programs
    • Outreach Programs
    • Outreach Programs Home
    • Project ECHO
    • Observer Programs
    • Comparative Effectiveness Training (CERTaIN)
  • Apply to SHP

    Choose from 12 allied health programs at School of Health Professions.

    Research Trainees

    View open postdoctoral and other research trainee positions.

    GME Fellowships

    Learn about our graduate medical education residency and fellowship opportunities.

Top We're here for you. Call us at 1-877-632-6789 or request an appointment online. Let's get started. Request an appointment online. Call Request appointment MyChart

• Diagnosis & Treatment
• Cancer Types
• Non-Hodgkin Lymphoma

Learn more about Non-Hodgkin Lymphoma Back

• Non-Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma Symptoms
  • Non-Hodgkin Lymphoma Diagnosis
  • Non-Hodgkin Lymphoma Treatment

Get details about our clinical trials that are currently enrolling patients.

View Clinical Trials | Close Share this article Via social media: Or copy the link: Copy to clipboard Copy B-cell Lymphoma

B-cell lymphoma is a type of non-Hodgkin lymphoma that originates in the B-cells. It is the most common type of lymphoma and about 85% of all lymphomas in the United States are B-cell. Common symptoms associated with lymphoma include painless enlargement of one or more lymph node areas, fever, night sweats, and weight loss.

Types of B-cell lymphoma

Diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of B-cell lymphoma. DLBCL typically affects older people and accounts for one out of three cases of non-Hodgkin lymphoma. This type of B-cell lymphoma usually begins as a mass in a lymph node, but can also form in particular sites such as bone, intestine, the spinal cord or brain.

Standard treatment for DLBCL generally involves months of conventional chemotherapy, and overall cure rates in the last 15 years have been about 70%.

Diffuse large B-cell lymphoma has long been treated as a single disease, but it is now categorized into many different subtypes based on their molecular features. There are two large subtypes: germinal center b-cell (GCB) and activated b-cell (ABC).

Targeted therapies that address the specific molecular features of these DLBCL subtypes are now in clinical trials, and standard therapy may soon depend on subtyping. Based on trials at MD Anderson, CAR T cell therapy is likely to be approved for relapsed or treatment-refractory DLBCL.

Diffuse large B-cell lymphoma can also be categorized based on where it develops. Site-specific forms include:

Primary mediastinal B-cell lymphoma (located within the chest, behind the sternum) has distinctive clinical and molecular features. It is significantly different than other types of DLBCL and, biologically, has more in common with classic Hodgkin lymphoma.

Primary central nervous system lymphoma is rare in general, but is more likely to develop in older populations, as well as those with compromised immune systems. It is almost always DLBCL, particularly the ABC subtype. It can sometimes present in tissues surrounding the eye or spinal cord, but is mostly found throughout the brain and spinal cord.

Follicular lymphoma

The cells of this type of B-cell lymphoma grow in circular structures (follicles), generally within lymph nodes. Follicular lymphomas typically grow slowly, but carry a risk of transformation to the fast-growing GCB-type DLBCL. In some cases, care starts with active surveillance, where the patient is closely monitored for signs of disease progression but is not given any treatments. Most patients are treated initially, however. Standard treatments include targeted therapy without chemotherapy. Around 80% of patients achieve many years of disease-free survival.

Small lymphocytic lymphoma (SLL)/Chronic lymphocytic leukemia (CLL)

The cancer cells in SLL and CLL are identical. The diseases differ based on where these cells are located. SLL cancer cells are mostly in the spleen and lymph nodes, while CLL cancer cells are found mainly in the blood and bone marrow. SLL/CLL predominantly affects older patients and progresses slowly. It can transform into an aggressive disease called Richter’s transformation. Several targeted therapies tested at MD Anderson are now approved or are being evaluated, and can provide years of disease-free survival.

• Learn more about chronic lymphocytic leukemia

Mantle cell lymphoma (MCL)

Mantle cell lymphoma usually affects the lymph nodes, spleen and bone marrow at the time of diagnosis, and is highly variable in its rate of progression. MCL is more likely to affect men and people older than 60. Several targeted therapies tested at MD Anderson are now approved or are being evaluated, and provide chemotherapy-free treatment options for many patients.

Learn more about mantle cell lymphoma

Marginal zone lymphoma

Marginal zone lymphomas are typically slow-growing B-cell lymphomas that comprise 5-10% of lymphoma cases. There are three distinct types, largely based on initial sites of involvement:

MALT lymphoma (extranodal marginal zone B-cell lymphoma or mucosa-associated lymphoid tissue lymphoma)

This is the most common type of MZL. MALT lymphoma originates outside the lymph nodes, often in the stomach. This type of B-cell lymphoma can also start in the skin, lungs or tissues in the mouth and around the eye. Bacterial and viral infections have been shown to cause MALT lymphomas.

Nodal marginal zone B-cell lymphoma

This slow-growing form of MZL is rare and primarily affects older women. It’s typically found in the lymph nodes and occasionally in bone marrow.

Splenic marginal zone B-cell lymphoma

This rare B-cell lymphoma is found almost exclusively in the spleen and bone marrow. It is more common in older men and has been associated with the hepatitis C virus. It is not unusual for an enlarged spleen, common with this type of B-cell lymphoma, to cause fatigue and discomfort.

Burkitt lymphoma

Burkitt lymphoma is a fast-growing B-cell lymphoma that accounts for 1-2% of all lymphomas. Occasionally found in adults, it is much more common in children, especially in boys.

The first-described type of Burkitt lymphoma, endemic to Africa, often presents as a facial tumor and is linked to infection with the Epstein-Barr virus. The variety of Burkitt lymphoma more often seen in the U.S. typically lacks a viral link. It often starts as a large abdominal tumor, less frequently in the testicles or ovaries, and can spread to cerebrospinal fluid.

Burkitt lymphoma is now better classified on the basis of molecular features. It can include some cases that may be confused with DLBCL, but do better with more aggressive chemotherapy.

Waldenstrom macroglobulinemia

Waldenstrom macroglobulinemia is a rare B-cell neoplasm that has features between lymphoma and multiple myeloma. It is most often found in the bone marrow, and typically becomes apparent from symptoms attributable to high blood levels of tumor-produced IgM immunoglobulin, or “macroglobulinemia”.

Learn more about Waldenstrom macroglobulinemia

Hairy cell leukemia

Despite the “leukemia” name, hairy cell leukemia (HCL) is sometimes considered a type of lymphoma, as the cells are B lymphocytes. It is slow-growing, and initial treatment (if any) may include splenectomy for symptoms due to splenic enlargement. Rates of long-term survival or cure are high.

B-cell lymphoma treatment

Treatment for B-cell lymphoma is similar to treatment for other types of non-Hodgkin lymphoma. These options include chemotherapy, radiation therapy, proton therapy, immunotherapy and stem cell transplantation.

Featured Articles

Lymphoma survivor uses AI to help explain her treatment

B-cell lymphoma survivor: I experienced marriage and motherhood, thanks to MD Anderson

4 things to know about marginal zone lymphoma

Stage III B cell lymphoma survivor: Go to MD Anderson first

View more View less

Clinical Trials

MD Anderson patients have access to clinical trials offering promising new treatments that cannot be found anywhere else. View Clinical Trials

Becoming Our Patient

Get information on patient appointments, insurance and billing, and directions to and around MD Anderson.

View New Patient Resources

Help #EndCancer

Give Now

Your gift will help make a tremendous difference. Donate

Donate Blood

Our patients depend on blood and platelet donations.

Make an appointment

Shop MD Anderson

Show your support for our mission through branded merchandise. 

View products